(Q33897927)

29 July 2017

1 reference

title

Reversing neurodegeneration: a promise unfolds (English)

1 reference

29 July 2017

1 reference

2

H Y Zoghbi

1 reference

29 July 2017

H T Orr

1

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 March 2000

1 reference

29 July 2017

1 reference

29 July 2017

volume

101

1 reference

29 July 2017

issue

1

1 reference

29 July 2017

page(s)

1-4

1 reference

Ubiquitin, cellular inclusions and their role in neurodegeneration

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2980617-0

7 January 2021

Degradation of alpha-synuclein by proteasome

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2980617-0

7 January 2021

Up-regulation of protein chaperones preserves viability of cells expressing toxic Cu/Zn-superoxide dismutase mutants associated with amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2980617-0

7 January 2021

Analysis of the role of heat shock protein (Hsp) molecular chaperones in polyglutamine disease

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2980617-0

7 January 2021

Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: implications for pathogenesis and therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2980617-0

7 January 2021

Chaperone suppression of aggregation and altered subcellular proteasome localization imply protein misfolding in SCA1.

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2980617-0

7 January 2021

Mutation of the E6-AP ubiquitin ligase reduces nuclear inclusion frequency while accelerating polyglutamine-induced pathology in SCA1 mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2980617-0

7 January 2021

A YAC mouse model for Huntington's disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration.

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2980617-0

7 January 2021

The tyrosine kinase negative regulator c-Cbl as a RING-type, E2-dependent ubiquitin-protein ligase

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2980617-0

7 January 2021

Aberrant protein deposition and neurological disease

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2980617-0

7 January 2021

Ataxin-1 nuclear localization and aggregation: role in polyglutamine-induced disease in SCA1 transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2980617-0

7 January 2021

Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2980617-0

7 January 2021

The ubiquitin pathway in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2980617-0

7 January 2021

Expanding our understanding of polyglutamine diseases through mouse models

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2980617-0

7 January 2021

RING fingers mediate ubiquitin-conjugating enzyme (E2)-dependent ubiquitination

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2980617-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2980617-0

1 reference

7 January 2021

Intragenic deletion in the gene encoding ubiquitin carboxy-terminal hydrolase in gad mice

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2980617-0

7 January 2021

Suppression of polyglutamine-mediated neurodegeneration in Drosophila by the molecular chaperone HSP70.

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2980617-0

7 January 2021

Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2980617-0

7 January 2021

10.1016/S0092-8674(00)80617-0

Identifiers

DOI

1 reference

29 July 2017

1 reference